Xontogeny Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Professionals
-
5
- Investments
-
34
- Portfolio
-
23
- Exits
-
7
Xontogeny General Information
Company Description
Founded in 2016, Xontogeny is an accelerator firm based in Boston, Massachusetts. The firm prefers to invest in the healthcare and life science sectors.
Business Details
Website
www.xontogeny.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 361 Newbury Street
- Suite 501
- Boston, MA 02115
- United States
Xontogeny Investments (34)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NephroDI Therapeutics | 11-Jun-2024 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| CereVasc | 10-May-2024 | Therapeutic Devices | Generating Revenue | |||
| Adaptilens | 29-Apr-2024 | Therapeutic Devices | Pre-Clinical Trials | |||
| Neurosterix | 02-Apr-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Avalyn Pharma | 22-Sep-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| A-Alpha Bio | 25-Jul-2023 | Drug Discovery | Pre-Clinical Trials | |||
| TORL BioTherapeutics | 10-Apr-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Cargo Therapeutics | 09-Feb-2023 | Drug Discovery | Generating Revenue | |||
| Delve Bio | 04-Jan-2023 | Early Stage VC | Biotechnology | Generating Revenue | ||
| Peroxitech | 13-Dec-2022 | Later Stage VC | Drug Discovery | Clinical Trials - General |
Xontogeny Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Avenge Bio | 01-Aug-2024 | Out of Business | |
| Landos Biopharma | 23-May-2024 | ||
| Forge Biologics | 21-Dec-2023 | ||
| Cargo Therapeutics | 10-Nov-2023 | ||
| Apogee Therapeutics | 13-Jul-2023 | ||
| Landos Biopharma | 04-Feb-2021 | IPO | |
| Quellis Biosciences | 28-Jan-2021 | Merger/Acquisition |
Xontogeny Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Xontogeny Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Perceptive Advisors | 8 |
|
|
||
| Wellington Management |
|
|
|||
| Janus Henderson Investors |
|
|
|||
| RA Capital Management |
|
|
|||
| RTW Investments |
|
|
Xontogeny FAQs
-
What is Xontogeny?
Founded in 2016, Xontogeny is an accelerator firm based in Boston, Massachusetts.
-
When was Xontogeny founded?
Xontogeny was founded in 2016.
-
Where is Xontogeny headquartered?
Xontogeny is headquartered in Boston, MA.
-
What is Xontogeny's total asset value?
Xontogeny has around in total assets under management.
-
How many investments has Xontogeny made?
Xontogeny has made 34 investments.
-
What has Xontogeny invested in?
Xontogeny has made numerous investments in companies like NephroDI Therapeutics, CereVasc, and Adaptilens within the Drug Discovery and Therapeutic Devices industries.
-
What has Xontogeny invested in recently?
Xontogeny's latest investment was on 11-Jun-2024 in NephroDI Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
